CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 11 enrolled
Drug / intervention
Gamma transcranial alternating current stimulation +3 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05907707
NCT05907707N/ACompleted

Effects of Transcranial Alternating Current Stimulation (tACS) at Gamma Band Frequencies on Memory Recall and Sleep in Healthy Elderly Participants

University of North Carolina, Chapel Hill·interventional·Posted Jun 18, 2023·Updated Apr 2, 2025

In Brief

A clinical study evaluating Gamma transcranial alternating current stimulation, Control transcranial alternating current stimulation, and 2 other interventions for Transcranial Alternating Current Stimulation and 4 related conditions. Completed, enrolled 11 participants across 1 site.

Detailed Summary

The purpose of this clinical trial is to investigate the feasibility and efficacy of non-invasive transcranial alternating current stimulation (tACS) at gamma frequency in enhancing memory recall and modulating sleep network dynamics measured by at-home electroencephalography (EEG) in healthy elderly people. Eligible participants will first collect sleep EEG at home for one night to acclimate to the data collection during sleep. Participants are then randomized into first undergoing either tACS at gamma band frequencies (i.e. 40Hz) or tACS at a control frequency (i.e. 21Hz). Stimulation is administered in the lab during a cognitive testing battery that includes memorizing items. After a night of sleep with EEG at home, participants return to the lab the following day to measure memory recall. Recall is performed again after five days. This sequence of encoding during stimulation in the lab, sleep EEG at home for one night, and recall is then repeated for the other stimulation condition about a week later. Participants are wearing an actigraphy wristband throughout the study period.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
202420252026
First PostedJun 18, 2023
Enrollment StartJun 28, 2023
Primary CompletionDec 28, 2023
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 3.0 years ago

Interventions

Gamma transcranial alternating current stimulationdevice

tACS (gamma frequency, 40Hz) during cognitive testing (about 40 minutes duration).

Control transcranial alternating current stimulationdevice

tACS (control frequency, 21Hz) during cognitive testing (about 40 minutes duration).

EEG headbanddevice

At-home, ambulatory, single-channel EEG headband which records brain activity during sleep

Actigraphy wristbanddevice

At-home, ambulatory, wrist-worn accelerometer which records levels of motor activity during the whole day